Literature DB >> 22778849

Synthesis and evaluation of novel chalcone derivatives with (99m)Tc/Re complexes as potential probes for detection of β-amyloid plaques.

Masahiro Ono1, Ryoichi Ikeoka, Hiroyuki Watanabe, Hiroyuki Kimura, Takeshi Fuchigami, Mamoru Haratake, Hideo Saji, Morio Nakayama.   

Abstract

Four (99m)Tc-labeled chalcone derivatives and their corresponding rhenium analogues were tested as potential probes for imaging β-amyloid plaques. The chalcones showed higher affinity for Aβ(1-42) aggregates than did (99m)Tc complexes. In sections of brain tissue from an animal model of AD, the four Re chalcones intensely stained β-amyloid plaques. In biodistribution experiments using normal mice, (99m)Tc-BAT-chalcone ([(99m)Tc]17) displayed high uptake in the brain (1.48% ID/g) at 2 min postinjection. The radioactivity washed out from the brain rapidly (0.17% ID/g at 60 min), a highly desirable feature for an imaging agent. [(99m)Tc]17 may be a potential probe for imaging β-amyloid plaques in Alzheimer's brains.

Entities:  

Keywords:  99mTc; Alzheimer’s disease; single photon emission computed tomography (SPECT) imaging; β-amyloid plaque

Mesh:

Substances:

Year:  2010        PMID: 22778849      PMCID: PMC3368688          DOI: 10.1021/cn100042d

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  25 in total

1.  Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.

Authors:  E D Agdeppa; V Kepe; J Liu; S Flores-Torres; N Satyamurthy; A Petric; G M Cole; G W Small; S C Huang; J R Barrio
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 2.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease.

Authors:  N A Dezutter; R J Dom; T J de Groot; G M Bormans; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1999-11

4.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

Authors:  Kooresh Shoghi-Jadid; Gary W Small; Eric D Agdeppa; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Stephen Read; Nagichettiar Satyamurthy; Andrej Petric; Sung-Cheng Huang; Jorge R Barrio
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

5.  Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Authors:  Seok Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

6.  IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.

Authors:  Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Bin Zhang; Daniel Skovronsky; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Journal:  Brain Res       Date:  2002-11-29       Impact factor: 3.252

7.  Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.

Authors:  Zhi-Ping Zhuang; Mei-Ping Kung; Alan Wilson; Chi-Wan Lee; Karl Plössl; Catherine Hou; David M Holtzman; Hank F Kung
Journal:  J Med Chem       Date:  2003-01-16       Impact factor: 7.446

8.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

9.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

10.  11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.

Authors:  Masahiro Ono; Alan Wilson; Jose Nobrega; David Westaway; Paul Verhoeff; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Journal:  Nucl Med Biol       Date:  2003-08       Impact factor: 2.408

View more
  16 in total

Review 1.  Recent progress in the development of metal complexes as β-amyloid imaging probes in the brain.

Authors:  Kaihua Chen; Mengchao Cui
Journal:  Medchemcomm       Date:  2017-05-16       Impact factor: 3.597

2.  Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease.

Authors:  Seema Bag; Sanjukta Ghosh; Rekha Tulsan; Abha Sood; Weihong Zhou; Christine Schifone; Michelle Foster; Harry LeVine; Béla Török; Marianna Török
Journal:  Bioorg Med Chem Lett       Date:  2013-03-14       Impact factor: 2.823

3.  Design of a multivalent bifunctional chelator for diagnostic 64Cu PET imaging in Alzheimer's disease.

Authors:  Hong-Jun Cho; Truc T Huynh; Buck E Rogers; Liviu M Mirica
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-24       Impact factor: 11.205

Review 4.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

5.  PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques.

Authors:  André F Martins; Jean-François Morfin; Anna Kubíčková; Vojtěch Kubíček; Frédéric Buron; Franck Suzenet; Milena Salerno; Adina N Lazar; Charles Duyckaerts; Nicolas Arlicot; Denis Guilloteau; Carlos F G C Geraldes; Eva Tóth
Journal:  ACS Med Chem Lett       Date:  2013-04-15       Impact factor: 4.345

6.  Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation.

Authors:  Dustin Wayne Demoin; Ashley N Dame; William D Minard; Fabio Gallazzi; Gary L Seickman; Tammy L Rold; Nicole Bernskoetter; Michael E Fassbender; Timothy J Hoffman; Carol A Deakyne; Silvia S Jurisson
Journal:  Nucl Med Biol       Date:  2016-08-31       Impact factor: 2.408

7.  Associating a negatively charged GdDOTA-derivative to the Pittsburgh compound B for targeting Aβ amyloid aggregates.

Authors:  André F Martins; Alexandre C Oliveira; Jean-François Morfin; Douglas V Laurents; Éva Tóth; Carlos F G C Geraldes
Journal:  J Biol Inorg Chem       Date:  2015-11-27       Impact factor: 3.358

8.  Method and Basis Set Analysis of Oxorhenium(V) Complexes for Theoretical Calculations.

Authors:  Dustin Wayne Demoin; Yawen Li; Silvia S Jurisson; Carol A Deakyne
Journal:  Comput Theor Chem       Date:  2012-08-09       Impact factor: 1.926

Review 9.  Mapping neuroreceptors with metal-labeled radiopharmaceuticals.

Authors:  S Chaturvedi; A Kaul; Puja P Hazari; Anil K Mishra
Journal:  Medchemcomm       Date:  2017-03-10       Impact factor: 3.597

10.  Mapping the binding site topology of amyloid protein aggregates using multivalent ligands.

Authors:  Elena Sanna; Margarida Rodrigues; Steven G Fagan; Timothy S Chisholm; Klara Kulenkampff; David Klenerman; Maria Grazia Spillantini; Franklin I Aigbirhio; Christopher A Hunter
Journal:  Chem Sci       Date:  2021-06-07       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.